Fischetto, R., Palladino, V., Mancardi, M. M., Giacomini, T., Palladino, S., Gaeta, A., . . . Giordano, P. (2020). Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience. Mol Genet Genomic Med.
Chicago ZitierstilFischetto, Rita, et al. "Substrate Reduction Therapy With Miglustat in Pediatric Patients With GM1 Type 2 Gangliosidosis Delays Neurological Involvement: A Multicenter Experience." Mol Genet Genomic Med 2020.
MLA ZitierstilFischetto, Rita, et al. "Substrate Reduction Therapy With Miglustat in Pediatric Patients With GM1 Type 2 Gangliosidosis Delays Neurological Involvement: A Multicenter Experience." Mol Genet Genomic Med 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.